Skip to main content
PMC home page
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 1992;122(1):35–44. doi: 10.1007/BF01321116

Viremic dissemination of mouse hepatitis virus-JHM following intranasal inoculation of mice

S W Barthold 1, Abigail L Smith 1
PMCID: PMC7086624  PMID: 1309644

Summary

Using a sensitive infant mouse bioassay to detect infectious virus, the pattern of mouse hepatitis virus (MHV) JHM dissemination in blood and other tissues was examined during the first 5 days following intranasal inoculation. MHV replicated in nasal turbinates of both susceptible BALB and resistant SJL mice from days 1 through 5, but BALB mice had higher titers on days 1 and 2. Viremia was detectable on days 1 through 5 in BALB mice, but only on days 3 and 5 in SJL mice. Transient virus replication occurred in the lungs of both mouse genotypes at 1 and 2 days, then ceased. This correlated with more consistently demonstrable virus in blood collected from the left atrium of the heart, compared to jugular vein, portal vein and right atrial blood. Virus was associated equally with the plasma and cellular fractions of blood on day 3, but was primarily in the buffy coat of the cellular fraction on day 5. Interferon-α/β was detected in serum and spleen, but not liver or brain of BALB mice or in any tissue of SJL mice. BALB serum and spleen interferon was first detected at 36h, peaked between 48 and 72h, and was undetectable by 108h. The distribution of virus in nose, cervical, axillary and mesenteric lymph nodes, spleen, Peyer's patch, thymus, bone marrow and liver was examined at 1, 2, and 3 days. The resulting pattern suggested lymphatic spread of virus to cervical lymph node and mesenteric lymph node as pathways of dissemination in addition to viremia.

Keywords: Left Atrium, Cervical Lymph Node, Mesenteric Lymph Node, Infectious Virus, Buffy Coat

References

  • 1.Barthold SW. Mouse hepatitis virus biology and epizootiology. In: Bhatt PN, Jacoby RO, Morse AC III, New AE, editors. Viral and mycoplasmal infections of laboratory rodents: effects on biomedical research. Orlando, FL: Academic Press; 1986. pp. 571–601. [Google Scholar]
  • 2.Barthold SW. Olfactory neural pathway in mouse hepatitis virus nasoencephalitis. Acta Neuropathol. 1988;76:502–506. doi: 10.1007/BF00686390. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Barthold SW, de Souza MS, Smith AL. Susceptibility of laboratory mice to intranasal and contact infection with coronaviruses of other species. Lab Anim Sci. 1990;40:481–485. [PubMed] [Google Scholar]
  • 4.Barthold SW, Smith AL. Mouse hepatitis virus strain-related patterns of tissue tropism in suckling mice. Arch Virol. 1984;81:103–112. doi: 10.1007/BF01309300. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Barthold SW, Smith AL. Response of genetically susceptible and resistant mice to intranasal inoculation with mouse hepatitis viurs JHM. Virus Res. 1987;7:225–239. doi: 10.1016/0168-1702(87)90030-X. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Boyle JF, Weismiller DG, Holmes KV. Genetic resistance of MHV correlates with absence of virus-binding activity on target tissues. J Virol. 1987;61:185–189. doi: 10.1128/jvi.61.1.185-189.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Furuta T, Goto Y, Tamura T, Kai C, Ueda K. Pulmonary vascular lesions in nude mice persistently infected with mouse hepatitis virus. Japan J Exp Med. 1979;49:423–428. [PubMed] [Google Scholar]
  • 8.Garlinghouse LE, Smith AL. Responses of mice susceptible or resistant to lethal infection with mouse hepatitis virus, strain JHM, after exposure by a natural route. Lab Anim Sci. 1985;35:469–472. [PubMed] [Google Scholar]
  • 9.Goto N, Hirano N, Aiuchi M, Hayashi T, Fujiwara K. Nasoencephalopathy of mice infected intranasally with a mouse hepatitis virus, JHM strain. Japan J Exp Med. 1977;47:59–70. [PubMed] [Google Scholar]
  • 10.Knobler RL, Oldstone MBA. Infection and involution of mouse thymus by MHV-4. Adv Exp Med Biol. 1986;218:451–453. doi: 10.1007/978-1-4684-1280-2_56. [DOI] [PubMed] [Google Scholar]
  • 11.Lavelle GC, Starr TJ. Effects of cortisone on interferon response of germfree mice to mouse hepatitis virus. J Reticuloend Soc. 1968;5:436–444. [PubMed] [Google Scholar]
  • 12.Lavi E, Gilden DH, Highkin MK, Weiss SR. MHV-A59 pathogenesis in mice. Adv Exp Med Biol. 1984;173:237–245. doi: 10.1007/978-1-4615-9373-7_24. [DOI] [PubMed] [Google Scholar]
  • 13.Le Prevost C, Levy-Leblond E, Virelizier J, Dupuy J. Immunopathology of mouse hepatitis virus type 3 infection. I. Role of humoral and cell-mediated immunity in resistance mechanisms. J Immunol. 1975;114:221–225. [PubMed] [Google Scholar]
  • 14.Piazza M, Pane G, DeRitis F. The fate of murine hepatitis virus (MHV-3) after intravenous injection into susceptible mice. Arch Ges Virusforsch. 1967;22:472–474. doi: 10.1007/BF01242969. [DOI] [PubMed] [Google Scholar]
  • 15.Rubinstein S, Familletti PC, Pestka S. Convenient assay for interferons. J Virol. 1981;37:755–758. doi: 10.1128/jvi.37.2.755-758.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Schindler L, Engler H, Kirschner H. Activation of natural killer cells and induction of interferon after injection of mouse hepatitis virus type 3 in mice. Infect Immun. 1982;35:869–873. doi: 10.1128/iai.35.3.869-873.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Smith AL, Winograd DF. Two enzyme immunoassays for the detection of antibody to rodent coronoaviruses. J Virol Methods. 1986;14:335–343. doi: 10.1016/0166-0934(86)90035-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Taguchi F, Goto Y, Aiuchi M, Hayashi T, Fujiwara K. Pathogenesis of mouse hepatitis virus infection. The role of nasal epithelial cells as a primary target of low-virulence virus, MHV-S. Microbiol Immunol. 1979;23:249–262. doi: 10.1111/j.1348-0421.1979.tb00461.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Taguchi F, Hirano N, Kiuchi Y, Fujiwara K. Difference in response to mouse hepatitis virus among susceptible mouse strains. Japan J Exp Med. 1976;20:293–302. doi: 10.1111/j.1348-0421.1976.tb00991.x. [DOI] [PubMed] [Google Scholar]
  • 20.Taguchi F, Siddell SG. Difference in sensitivity to interferon among mouse hepatitis viruses with high and low virulence for mice. Virology. 1985;147:41–48. doi: 10.1016/0042-6822(85)90225-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Taguchi F, Yamada A, Fujiwara K. Factors involved in the age-dependent resistance of mice infected with low virulence mouse hepatitis virus. Arch Virol. 1979;62:333–340. doi: 10.1007/BF01318107. [DOI] [PubMed] [Google Scholar]
  • 22.Virelizier JL, Virelizier AM, Allison AC. The role of circulating interferon in the modifications of immune responsiveness by mouse hepatitis virus (MHV-3) J Immunol. 1976;117:748–753. [PubMed] [Google Scholar]
  • 23.Wege H, Siddell S, ter Meulen V. The biology and pathogenesis of coronaviruses. Curr Top Microbiol Immunol. 1982;99:165–200. doi: 10.1007/978-3-642-68528-6_5. [DOI] [PubMed] [Google Scholar]
  • 24.Williams RF, Jiang G-S, Snyder SW, Frana WF, Holmes KV. Purification of the 110-kilodalton glycoprotein receptor for MHV (MHV)-A59 from mouse liver and identification of a nonfunctional, homologous protein in MHV-resistant SJL/J mice. J Virol. 1990;64:3817–3823. doi: 10.1128/jvi.64.8.3817-3823.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Yamada Y, Taguchi F, Fujiwara K. T-lymphocyte.dependent difference in susceptibility between DDD and C3H mice to mouse hepatitis virus, MHV-3. Japan J Exp Med. 1979;49:413–421. [PubMed] [Google Scholar]

Articles from Archives of Virology are provided here courtesy of Nature Publishing Group

RESOURCES